Skip to main content
. Author manuscript; available in PMC: 2019 Aug 11.
Published in final edited form as: Nat Med. 2019 Feb 11;25(3):477–486. doi: 10.1038/s41591-018-0337-7

Table 1.

Patient characteristics by group. IDH: isocitrate dehydrogenase. MGMT: O6-methylguanine DNA methyltransferase. SD: standard deviation. SEM: standard error of the mean.

Patient Characteristics
Neoadjuvant
(n=16)
Adjuvant
(n=16)
Total
(n=32)
Demographics
 Age at enrollment - years, mean ± SD 55.4 ± 13.5 59.3 ± 12.3 57.4 ± 12.8
 Gender, no. (%)
  Male 7 (44) 5 (31) 12 (38)
  Female 9 (56) 11 (69) 19 (63)
Karnofsky performance status, mean ± SD 80 ± 8.9 86 ± 6.2 83 ± 8.2
Steroid use at registration
 No. of patients receiving steroids 7 7
 Daily dosage, median, mg/day (range) 0 (0-4) 0 (0-6)
MGMT status, no. (%)
 Methylated 6 (38) 11 (69) 17 (53)
 Unmethylated 7 (44) 4 (26) 11 (34)
 Unknown 3 (19) 1 (6) 4 (13)
IDH status, no. (%)
 Wild-type 12 (75) 13 (81) 25 (78)
 Mutant 3 (19) 2 (13) 5 (16)
 Unknown 1 (6) 1 (6) 2 (6)
Pre-surgery tumor volume, cm3, mean ± SEM 21.8 ± 6.2 18.9 ± 3.2